Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 27593544)

Published in Aliment Pharmacol Ther on September 04, 2016

Authors

A Horvath1, B Leber2,3, B Schmerboeck4, M Tawdrous1, G Zettel1, A Hartl1, T Madl5, S Stryeck5, D Fuchs6, S Lemesch1, P Douschan1, E Krones1, W Spindelboeck1, F Durchschein1, F Rainer1, G Zollner1, R E Stauber1, P Fickert1, P Stiegler4, V Stadlbauer1

Author Affiliations

1: Department of Gastroenterology and Hepatology, Medical University of Graz, Graz, Austria.
2: Department of Transplantation Surgery, Medical University of Graz, Graz, Austria. bettina.leber@medunigraz.at.
3: Centre for Biomarker Research in Medicine (CBmed), Graz, Austria. bettina.leber@medunigraz.at.
4: Department of Transplantation Surgery, Medical University of Graz, Graz, Austria.
5: Institute of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.
6: Division of Biological Chemistry, Biocentre, Medical University of Innsbruck, Innsbruck, Austria.

Associated clinical trials:

Influence of Probiotics on Infections in Cirrhosis (PIC) | NCT01607528

Articles cited by this

Concern Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet (2008) 10.70

Measuring the global burden of disease. N Engl J Med (2013) 5.84

Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology (2004) 4.06

The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota. Sci Transl Med (2014) 3.32

Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol (2014) 3.26

Bacterial translocation (BT) in cirrhosis. Hepatology (2005) 3.07

Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol (2001) 2.73

Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis (2008) 2.47

The severity of circulating neutrophil dysfunction in patients with cirrhosis is associated with 90-day and 1-year mortality. Aliment Pharmacol Ther (2014) 2.10

Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation--a randomized, double-blind trial. Am J Transplant (2005) 2.08

Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome. Hepatology (2007) 2.08

Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. J Clin Gastroenterol (2005) 1.93

Evidence of neutrophil functional defect despite inflammation in stable cirrhosis. J Hepatol (2011) 1.90

Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice. Gastroenterology (2014) 1.89

Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial. Gastroenterology (2014) 1.79

Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci U S A (2009) 1.67

Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol (2008) 1.63

Intestinal permeability--a new target for disease prevention and therapy. BMC Gastroenterol (2014) 1.52

Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflamm Res (2003) 1.32

Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality. Gut (1997) 1.27

Recommendations for probiotic use-2011 update. J Clin Gastroenterol (2011) 1.19

Neopterin: a review. Exp Dermatol (1999) 1.18

Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. J Hepatol (2008) 1.17

Intestinal permeability is increased in patients with advanced cirrhosis. Hepatogastroenterology (2003) 1.12

Ammonia impairs neutrophil phagocytic function in liver disease. Hepatology (2008) 1.07

Infectious complications of acute and chronic liver disease. Semin Respir Crit Care Med (2012) 1.05

The effect of probiotics on gut flora, level of endotoxin and Child-Pugh score in cirrhotic patients: results of a double-blind randomized study. Eur J Gastroenterol Hepatol (2007) 1.02

Circulating neutrophil dysfunction in acute liver failure. Hepatology (2012) 0.97

Probiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained men; a randomized, double-blinded, placebo-controlled trial. J Int Soc Sports Nutr (2012) 0.95

Role of Toll-like receptors 2, 4, and 9 in mediating neutrophil dysfunction in alcoholic hepatitis. Am J Physiol Gastrointest Liver Physiol (2008) 0.93

Endotoxin priming of neutrophils requires endocytosis and NADPH oxidase-dependent endosomal reactive oxygen species. J Biol Chem (2012) 0.89

Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia. World J Hepatol (2015) 0.88

Novel Strategies in the Prevention and Treatment of Urinary Tract Infections. Pathogens (2016) 0.83

Impaired innate immune response of leukocytes from ascitic fluid of patients with spontaneous bacterial peritonitis. J Leukoc Biol (2015) 0.80

Intestinal flora, probiotics, and cirrhosis. Ann Hepatol (2008) 0.79

Endotoxin measures in patients' sample: how valid are the results? J Hepatol (2007) 0.79

Altered functionality of anti-bacterial antibodies in patients with chronic hepatitis C virus infection. PLoS One (2013) 0.79

Immunosuppression and probiotics: are they effective and safe? Benef Microbes (2015) 0.79

Rapid killing of Capnocytophaga canimorsus and Capnocytophaga cynodegmi by human whole blood and serum is mediated via the complement system. Springerplus (2015) 0.78

Influence of neopterin on generation of reactive species by myeloperoxidase in human neutrophils. Biochim Biophys Acta (2004) 0.77